Although ALP impairment is frequently observed in the brain in AD patients and transgenic AD models [10–14], the exact mechanisms leading to the impairment of ALP-mediated clearance of Aβ and tau are largely unknown. The gene discussed is MAPT; the disease is Alzheimer disease.